Company: Biogen Idec Inc

The "Mad Money" host shares his earnings expectations for Biogen Idec, Cummins, Emerson Electric and Chesapeake Energy.   Read More

Since the S&P 500 touched a multi-year high on April 2, the index is down about 3.8 percent.  Should investors use the selloff as a buying opportunity?   Read More

The Spectrum Pharmaceuticals growth party is over.    Read More

Take a look at some of Wednesday’s morning movers:   Read More

Technology stocks have been gaining momentum in 2012, up eight of the last nine weeks.  However, over the last 12 months, consumer discretionary and health care companies have really powered the rally.   Read More

Could there be a correlation between leap years and market performance?    Read More

Speculation has its place, but Cramer's researcher thinks there is lots of opportunity to profit from established companies, too.   Read More

Although selecting the best of breed in the dog show may be a mysterious science to some, picking outliers in the stock market is vastly more straightforward.     Read More

Cramer thinks big pharma stocks could soon pop, so here's his preferred plays.   Read More

Find out why he’s bullish on this biotech name.   Read More